Bone morphogenic protein-4 contributes to venous endothelial dysfunction in patients with diabetes undergoing coronary revascularization

Annals of Thoracic Surgery

Volumn 95, Issue 4, 2013, Pages 1331-1339

  Hu, Jia ^a,b   Liu, Jian ^b   Kwok, Micky W T ^a   Wong, Randolph H L ^a   Huang, Yu ^b   Wan, Song ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; GLUCOSE; HYDROETHIDINE; NOGGIN; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ENDOTHELIAL DYSFUNCTION; EX VIVO STUDY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAPHENOUS VEIN; UMBILICAL VEIN; VENOUS ENDOTHELIAL DYSFUNCTION; WESTERN BLOTTING;

AGED; ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 4; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; SAPHENOUS VEIN; SWINE; VASOCONSTRICTION;

EID: 84875347393     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.12.028     Document Type: Article

References (30)

1. L.D. Hillis, P.K. Smith, J.L. Anderson 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 124 2011 e652 e735
2. P. Kolh, W. Wijns, N. Danchin Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI) Guidelines on myocardial revascularization Eur J Cardiothorac Surg 38 2010 S1 S52
3. M.E. Farkouh, M. Domanski, L.A. Sleeper FREEDOM trial investigators Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
4. S.K. Singh, N.D. Desai, S.D. Petroff Radial Artery Patency Study Investigators The impact of diabetic status on coronary artery bypass graft patency: insights from the radial artery patency study Circulation 118 2008 S222 S225
5. R.H. Mehta, E. Honeycutt, L.K. Shaw, M.H. Sketch Jr Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions Am Heart J 156 2008 728 735
6. J.A. Vita Endothelial function Circulation 124 2011 e906 e912
7. N. Shukla, J.Y. Jeremy Pathophysiology of saphenous vein graft failure: a brief overview of interventions Curr Opin Pharmacol 12 2012 114 120
8. M. Chello, C. Spadaccio, M. Lusini Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure Diabetes Metab Res Rev 25 2009 420 426
9. L.M. Leong, P.M. Brickell Bone morphogenic protein-4 Int J Biochem Cell Biol 28 1996 1293 1296
10. Z.I. Ungvari Endothelium-derived bone morphogenic protein inhibitors may counteract the proatherogenic vascular effects of bone morphogenic protein 4 Circulation 116 2007 1221 1223
11. H. Jo, H. Song, A. Mowbray Role of NADPH oxidases in disturbed flow- and BMP4-induced inflammation and atherosclerosis Antioxid Redox Signal 8 2006 1609 1619
12. G.P. Sorescu, M. Sykes, D. Weiss Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response J Biol Chem 278 2003 31128 31135
13. G.P. Sorescu, H. Song, S.L. Tressel Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase Circ Res 95 2004 773 779
14. K. Chang, D. Weiss, J. Suo Bone morphogenic protein inhibitors are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein inhibitors in inflammation and atherosclerosis Circulation 116 2007 1258 1266
15. A.E. Vendrov, N.R. Madamanchi, Z.S. Hakim, M. Rojas, M.S. Runge Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis Circ Res 98 2006 1254 1263
16. S. Miriyala, M.C. Gongora Nieto, C. Mingone Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation Circulation 113 2006 2818 2825
17. W.T. Wong, X.Y. Tian, Y. Chen Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension Circ Res 107 2010 984 991
18. X.Y. Tian, L.H. Yung, W.T. Wong Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38MAPK and JNK pathway J Mol Cell Cardiol 52 2012 237 244
19. American Diabetes Association Standards of medical care in diabetes - 2011 Diabetes Care 34 Suppl 1 2011 S11 S61
20. N. Kang, C.S. Ng, J. Hu Role of osteopontin in the development of neointimal hyperplasia in vein grafts Eur J Cardiothorac Surg 41 2012 1384 1389
21. S.J. George, S. Wan, J. Hu, J.L. Johnson, R. MacDonald, A.H. Baker Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy Circulation 124 2011 S135 S142
22. Z. Fatehi-Hassanabad, C.B. Chan, B.L. Furman Reactive oxygen species and endothelial function in diabetes Eur J Pharmacol 636 2010 8 17
23. Y. Li, S. Liu, Z. Zhang RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation PLoS One 7 2012 e35016
24. W.T. Wong, S.L. Wong, X.Y. Tian, Y. Huang Endothelial dysfunction: the common consequence in diabetes and hypertension J Cardiovasc Pharmacol 55 2010 300 307
25. Y. Yao, B.J. Bennett, X. Wang Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification Circ Res 107 2010 485 494
26. X. Yang, L. Long, M. Southwood Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension Circ Res 96 2005 1053 1063
27. D.B. Frank, A. Abtahi, D.J. Yamaguchi Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension Circ Res 97 2005 496 504
28. C.R. Dhore, J.P. Cleutjens, E. Lutgens Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques Arterioscler Thromb Vasc Biol 21 2001 1998 2003
29. G.P. Sorescu, M. Sykes, D. Weiss Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response J Biol Chem 278 2003 31128 31135
30. G.P. Sorescu, H. Song, S.L. Tressel Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase Circ Res 95 2004 773 779